09:24 AM EST - Oncolytics Biotech Inc : Announced it has entered into an agreement with Leede Jones Gable Inc. as underwriter and bookrunner, pursuant to which the Underwriter has agreed to purchase, on a bought-deal basis, 6,667,000 units for gross proceeds to the Company of US$15,000,750 at a price of US$2.25 per Equity Unit. Each Equity Unit will consist of one common share of the Company and one Common Share purchase warrant. Each Warrant will entitle the holder thereof to purchase one Common Share at an exercise price of US$2.81 at any time up to 60 months following the Closing. Oncolytics Biotech Inc
shares T.ONC are trading unchanged at $3.70.
Full Press Release: https://www.baystreet.ca/quotedata/quote.aspx?ticker=ONCY&qmodStoryID=6871458444465399
